Professor, Oncology, Mayo Medical School
Oncology
Dr. Charles Erlichman, MD
|
|
Give Review
Doctor Charles Erlichman, MD practices Oncology. He over the years received 1 awards: "Fellow (FACP)". Dr. Charles Erlichman is a published doctor and has 18 publications published. The lastest was: 'Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Phase I trial of FOLFIRI in combination with sorafenib and bevacizumab in patients with advanced gastrointestinal malignancies.
- Gene Expression Profiling Identifies Responsive Patients with Cancer of Unknown Primary Treated with Carboplatin, Paclitaxel, and Everolimus: NCCTG N0871 (Alliance).
- Safety and activity of temsirolimus and bevacizumab in patients with advanced renal cell Carcinoma previously treated with tyrosine kinase inhibitors: a phase 2 consor...
- Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.
- A phase II study of AZD2171 (cediranib) in the treatment of patients with Acute myeloid leukemia or high-risk myelodysplastic syndrome.
- Dinaciclib, a novel CDK inhibitor, demonstrates encouraging single agent activity in patients with relapsed multiple Myeloma.
- Phase I trial of everolimus, gemcitabine and cisplatin in patients with solid Tumors.
- UGT1A1 genotype-guided phase I study of irinotecan, oxaliplatin, and capecitabine.
- Akt inhibitor MK2206 selectively targets CLL B-cell receptor induced cytokines, mobilizes lymphocytes and synergizes with bendamustine to induce CLL apoptosis.
- Phase I dose escalation study of the PKCι inhibitor aurothiomalate for advanced non-small-cell lung Cancer, ovarian Cancer, and pancreatic Cancer.
- Phase 1 study of sorafenib in combination with bortezomib in patients with advanced malignancies.
- A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast Cancer.
- Phase I study of tanespimycin in combination with bortezomib in patients with advanced solid malignancies.
- Biomarker-driven trial in metastatic pancreas Cancer: feasibility in a multicenter study of saracatinib, an oral Src inhibitor, in previously treated pancreatic Cancer.
- A phase 2 trial of flavopiridol (Alvocidib) and cisplatin in platin-resistant ovarian and primary peritoneal Carcinoma: MC0261.
- Gemcitabine and Irinotecan as First-Line Therapy for Carcinoma of Unknown Primary: Results of a Multicenter Phase II Trial.
- Phase 2 trial of daily, oral Polyphenon E in patients with asymptomatic, Rai stage 0 to II chronic lymphocytic Leukemia.
Schools
University Of Toronto Faculty Of Medicine
Mt Sinai
Princess Margaret Hospital
Toronto Western Hospital
National Canc Institute Nih
Procedures Preformed
- Plasmapheresis
Conditions Treated
- Acute Leukemia
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Fellow (FACP)
Education
-
University of Toronto Faculty of Medicine
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1356311450 | |
| NPPES Provider LastName | ERLICHMAN | |
| NPPES Provider FirstName | CHARLES | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 19.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1356311450 |
| Last Name Of The Provider | ERLICHMAN |
| First Name Of The Provider | CHARLES |
| View All |
Similar Doctors
|
|
Dr. Kiernan J. Minehan, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Edward T. Creagan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert B. Diasio, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Axel F. Grothey, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Andreas S. Beutler, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Rakhee R. Vaidya, MD
This Doctor is OpenDoctor Recommended.
|